Skip to main content

D. E. Shaw & Co., Inc.

Position in CRL — Charles River Laboratories International, Inc.

CIK 1009207 New York, NY

Position in CRL

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$33,375,817
-$52,625,595 QoQ
Shares Held
193,483
-55.1% QoQ
Ownership
0.402%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 99.12136983610964.ToString("F0")% Shared 0.ToString("F0")% None 0.8786301638903676.ToString("F0")%

Common Shares in CRL Over Time

Shares Held

Position Value (USD)

Derivatives in CRL

reported options exposure · as of Sep 30, 2025
CallValue
$0
CallShares
0
PutValue
$250,336
PutShares
1,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

D. E. Shaw & Co., Inc. holds $1,676,976,764 across 27 Diagnostics & Research names. CRL ranks #10 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRL

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $33,375,817 193,483
2025-12-31 $86,001,412 431,128
2025-09-30 $250,336 1,600
2025-09-30 $150,129,158 959,537
2025-06-30 $92,102,992 607,019
2025-06-30 $242,768 1,600
2025-03-31 $240,832 1,600
2024-12-31 $295,360 1,600
2024-12-31 $15,627,497 84,656
2023-12-31 $1,148,194 4,857
2023-09-30 $219,497 1,120
2023-03-31 $2,426,280 12,022
2022-12-31 $7,563,091 34,709
2022-09-30 $19,883,097 101,032
2022-06-30 $2,139,700 10,000
2022-06-30 $35,833,555 167,470
2022-03-31 $2,839,700 10,000
2022-03-31 $30,714,195 108,160
2021-12-31 $381,301 1,012
2021-12-31 $5,463,310 14,500
2021-09-30 $2,682,355 6,500
2021-09-30 $4,126,700 10,000
2021-09-30 $1,166,618 2,827
2021-06-30 $311,472 842
2020-12-31 $3,824,357 15,306
2020-09-30 $5,121,166 22,615
2020-06-30 $6,198,316 35,551
2020-03-31 $7,098,555 56,244